Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Phase 1	STARTED	Apremilast	20
Phase 1	STARTED	Placebo	10
Phase 1	COMPLETED	Apremilast	12
Phase 1	COMPLETED	Placebo	9
Phase 1	NOT COMPLETED	Apremilast	8
Phase 1	NOT COMPLETED	Placebo	1
Eligibility Determination for Phase 2	STARTED	Apremilast	12
Eligibility Determination for Phase 2	STARTED	Placebo	9
Eligibility Determination for Phase 2	COMPLETED	Apremilast	1
Eligibility Determination for Phase 2	COMPLETED	Placebo	9
Eligibility Determination for Phase 2	NOT COMPLETED	Apremilast	11
Eligibility Determination for Phase 2	NOT COMPLETED	Placebo	0
Phase 2	STARTED	Apremilast	1
Phase 2	STARTED	Placebo	9
Phase 2	COMPLETED	Apremilast	0
Phase 2	COMPLETED	Placebo	1
Phase 2	NOT COMPLETED	Apremilast	1
Phase 2	NOT COMPLETED	Placebo	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02684123/flow